Announcing Research 101 | UMR Answers Common Questions About NIH Research in this New Fact Sheet Series
Why Invest in NIH Research? | UMR Offers Fact Sheets Explaining Why Congress Must #keepNIHstrong
Read UMR's Statement on the House Appropriations Committee's Passage of FY23 Labor-HHS Funding Bill
NIH's Role In Sustaining the U.S. Economy | 2022 Update Now Available

A participant in the NIH 2019-2020 Medical Research Scholars Program.

Photo Credit: National Institutes of Health

About This Photo

BIO’s Dr. Michelle McMurry-Heath Letter to President Biden Discusses Collaboration To Boost Access to COVID-19 Treatments

Dr. Michelle McMurry-Heath, president and CEO of the Biotechnology Innovation Organization (BIO), sent a letter to President Biden outlining ways the public and private sectors can best work with global partners to ensure that patients around the world get access to COVID vaccines, therapeutics, and diagnostics. The letter, written on behalf of BIO members, highlights the importance of the COVAX and “ACT-Accelerator” initiatives to increase global vaccine access. It also makes clear industry concerns about the proposed “TRIPS waiver” in helping end this pandemic.